Skip to main content
SpringerLink
Log in

Sartan zur Migräneprophylaxe ebenso wirksam wie die Standardtherapie

Patienten mit häufigen Migräneattacken

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenz

  1. Tronvik E et al. JAMA 2002; 289: 65–69

    Google Scholar 

Literatur

  • Stovner LJ, Linde M, Gravdahl GB et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebocontrolled, double cross-over study. Cephalalgia 2013; doi:10.1177/0333102413515348

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie, Universitätsklinikum Essen, Deutschland

    Hans-Christoph Diener (Direktor)

Authors
  1. Hans-Christoph Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Christoph Diener.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diener, HC. Sartan zur Migräneprophylaxe ebenso wirksam wie die Standardtherapie. InFo Neurologie 16, 21 (2014). https://doi.org/10.1007/s15005-014-0753-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-014-0753-2

Search

Navigation